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INTRODUCTION 
Antimicrobial resistance is a problem of worldwide health 
systems, resulting in failure, high treatment costs and 
increased mortality. An increase production of β-lactamase by 
Gram-negative multiresistant in the organisms, such as 
extended spectrum β-lactamase (ESBL), or plasmid-mediated 
carbapenems-producing bacteria, is a particular concern [1]. 
Let us mention that the main reservoirs of the different Gram-
negative species are the environment, intestines of animals 
and humans, then these organisms can result in infections 
acquired on the community in humans. Due to the presence 
of co-resistance with other classes of antibiotics (including 
fluoroquinolones and aminoglycosides), the antibiotic 
treatment of infections caused by these organisms is a 
challenge [2]. The diffusion of these β-Lactamases is facilitated 
by horizontal transfers via mobile genetic elements (integrons,  
 
transposons and plasmids) and bacterial clonal proliferation 
[3]. Overall, surveillance data for antimicrobial resistance varies 
from country to country, ranging from the lack of national 
surveillance programs [1] 
In recent years, the emergence of multiresistant bacteria, 
mainly related to the pressure of antibiotic selection and 
hygiene, concern to the medical world as in Madagascar [4].  
ESBL in Madagascar were initially isolated between 2005 and 
2006 of acquired urinary tract infections in the community [5]. 
They were then isolated in epidemic to two pediatric units in 
2006. More recently, ESBL have been isolated from several 
infections acquired in different surgical and intensive care 
units Antananarivo [6].  In pediatrics, Andriatahina et al 
reported a fecal carriage of enteric bacteria producing an 
enlarged-spectrum β-lactamase (ESBL) before and after 
hospitalization respectively 21% and 51% of cases with a major 
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Introduction: Gram-negative bacilli are often responsible for rectal colonization in 
children. These bacilli normally sensitive to third generation cephalosporins (3GC) 
have acquired disturbing antibiotic resistance in recent years, hence the interest of 
our study. The aims are to monitor the epidemiological evolution resistance of 
Enterobacteriaceae with antibiotics in particular β-lactams, estimate the prevalence 
of enterobacteria responsible for rectal colonization and their resistance to 3GC. 
Material and methods: This is a descriptive prospective study of Enterobacteriaceae 
in children attending Ambohimiandra Hospital for a period of 3 months (from 01 
August to 31 October 2015). We have done a rectal swab of all the children whom 
we have parental consent. The samples were processed at the Laboratory of Medical 
Biology Faravohitra. The parameters studied are the antecedent of therapy 
antibiotic, notion of recent hospitalization and the results of microbiological 
examinations. Results: Of the 55 bacteriological samples obtained, 39 strains of 
Enterobacteriaceae were isolated, Escherichia coli (n = 12), Enterobacter cloacae (n 
= 13), Citrobacter spp (n = 1), Salmonella spp. (N = 5) and Shigella spp (n = 2), Proteus 
mirabilis (n = 1). Six isolated strains (50%) of Escherichia coli showed resistance to 
ceftriaxone, of which 4 (33.33%) produced ESBL. Conclusion: Gram-negative bacilli 
responsible for colonization of the digestive tract have several resistances to β-
lactams, in particular 3GC, by the production of enzymes (Expanded spectrum beta-
lactamase or ESBL and cephalosporinase or CASE) which hydrolyze these antibiotics. 
Measures to combat the spread of these phenomena resistance must be 
implemented in the Malagasy community to limit them. 
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risk factor for the notion of prior hospitalization [7].  In intensive 
care and surgical services at two hospitals in the capital, 
Randrianirina and al, found ESBL strains in more than 30% of 
the bacteria isolated from different bacteriological samples to 
the patients included [8].  At the community level, Herindrainy 
and al. Reported a fecal port of Gram-negative ESBL bacillus in 
10% of outpatients [9]. Another study on antimicrobial 
resistance of uropathogenic germs in an extra-hospital 
environment showed a resistance rate to ceftriaxone in 6% of 
the Enterobacteriaceae [10]. In addition, patients with ESBL 
infection and other third-generation cephalosporin-resistant 
bacteria are usually colonized by these bacteria in the 
intestinal tract. Spontaneous loss of ESBL positive colonizers 
occurs but is significantly delayed in repeated hospitalizations 
and antibiotic treatments [11,12].  
The objective was to evaluate the resistance profile of 
enterobacteria isolated from rectal sampling in children 
attending the Ambohimiandra Hospital 
MATERIALS & METHODS 
It is a descriptive observational prospective study, carried out 
over a period of 3 months (01 August to 31 October 2015), in 
the laboratory of Medical Biology, Faravohitra of 
Antananarivo.  To better understand the extent of the 
problem, it is important to expand the databases on the 
existence of these strains in the various community sectors. In 
this sense, a preliminary study was carried out in the 
laboratory of medical biology, Faravohitra of Antananarivo, 
Madagascar. The objective was to evaluate the resistance 
profile of enterobacteria isolated from rectal sampling in 
children attending the Ambohimiandra Hospital. It is a 
prospective study, carried out over a period of 3 months (01 
August to 31 October 2015), in the laboratory of Medical 
Biology, Faravohitra of Antananarivo. We included all children 
(1-13years old) hospitalized in the ambohimiandra university 
hospital with the consent of their parent, children with or 
without clinical manifestations of a digestive infection. The 
parameters studied were the history of antibiotic therapy, the 
history of recent hospitalization, and the results of 
microbiological examinations. Collected specimens were sent 
directly to the Laboratory of Training and Research in Medical 
Biology and immediately plated onto DCL agar 
(Difco® Laboratories Inc., Detroit, MI, USA) and incubated 
statically for 24–48 h at 37°C. Every colony type was tested for 
Gram staining and oxidase activity. Oxidase-negative Gram-
negative bacilli were identified with the API 20E system 
(bioMérieux, Marcy l’Etoile, France). The sensitivity of the 
isolated Enterobacteriaceae was evaluated using the diffusion 
technique on solid medium following the recommendations of 
the Antibiogram Committee of the French Microbiology 
Society [1]. Ten antibiotics were tested: amoxicillin, ticarcillin, 
cefalotin, cefoxitin, ceftriaxone, gentamicin, tetracycline, 
ciprofloxacin, cotrimoxazole, amoxicillin-clavulanic acid. Two 
types of multiresistant enterobacterium have been 
particularly sought: ESBL-producing Enterobacteriaceae 
characterized by their ability to hydrolyze penicillins and 
cephalosporins of 1st (1CG), 2nd (2CG), 3rd (3CG) and 4th 
generation but whose action Is inhibited by the presence of an 
inhibitor of Β-lactamase such as clavulanic acid thus making it 
possible to detect them by the presence of synergy between 
clavulanic acid and a 3CG; the hyperproductive strains of 
cephalosporinase whose cephalosporin hydrolysis is not 
inhibited by clavulanic acid (absence of synergy between 
clavulanic acid and a 3CG). 
RESULTS 
Of the 55 bacteriological samples obtained, 39 strains of 
Enterobacteriaceae were isolated, including Escherichia coli (n 
= 12), Enterobacter cloacae (n = 13), Citrobacter spp (n = 1), 
Salmonella spp. (N = 5) and Shigella spp (n = 2), Proteus 
mirabilis (n = 1). 
Six isolated strains (50%) of Escherichia coli showed resistance 
to ceftriaxone, of which 4 (33.33%) produced ESBL. In addition, 
all strains exhibited resistance associated with 
fluoroquinolone, cotrimoxazole, and tetracycline while 
maintaining sensitivity to gentamicin. 
Table 1: Carriage rectal of the Enterobacteria according to 
hospitalization history . 
 Carriage 
rectal 
positive (%) 
Carriage 
rectal 
negative (%) 
Total (%) 
Previous 
Hospitalization 
18 (90) 2 (10) 20 (36.4) 
No hospitalization 11 (31.4) 24 (68.5) 35 (63.6) 
p-value = 0,001 
Table 2: Carriage rectal of the Enterobacteria according to the 
antecedent administration antibiotic. 
 Positive rectal 
carriage (%) 
Negative rectal 
carriage (%) 
Total (%) 
History of 
antibiotic 
therapy 
9 (64.7) 5 (35.7) 14 (25.5) 
No antibiotic 
therapy 
20 (48.8) 21 (51.2) 41 (74.5) 
 
DISCUSSION  
 
These results confirm that it is classical to find a predominance 
of Escherichia coli (33,33%) in rectal colonization, this is similar 
to some study (32.2%)[7].They also confirm the presence of 
multidrug-resistant strains in the community. The associated 
resistance to the most accessible antibiotics inexorably limits 
the choice of antibiotic to be instituted for proper treatment. 
Moreover, this worrying presence hampers the current 
probabilistic antibiotic therapy, which is usually inspired by the 
antimicrobial resistance patterns found in Europe, partly the 
rate of transport of Enterobacteriaceae among young children 
in the French community (4.6%) [13,14]. Intestinal colonization 
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by ESBL producing isolates has a high risk of developing ESBL 
infection [15] and this intestinal transport is a factor in 
Escherichia coli infection producing ESBL[16]. In addition, the 
prevalence of ESBL transmission in children varies between 
studies and geographic areas. It ranges from 0.1% in Bolivia 
and Peru [17] to 31% in Niger [18]. These results suggest that 
studies of a broader population should be undertaken to 
statistically support these findings and to assess other risk 
factors and determinants of the carrying of these 
multiresistant bacteria in community and hospital settings. 
These factors include the notion of prior hospitalization and 
the history of antibiotic therapy. Regarding the relationship 
between this carriage rectal of multiresistant 
Enterobacteriaceae and the notion of prior hospitalization is 
significant. According to Andriatahina T. and al hospitalization 
in the past 30 days (adjusted OR = 7.4 [95% CI: 2.9-18.3]) was 
one significant risk factors for the acquisition of an ESBL with 
the previous antibiotic dose (OR adjusted = 4.1 (95% CI: 1.8-
9.4)) [19]. This study therefore reinforces the interest of setting 
up a strategy to combat the spread of these multiresistant 
bacteria see on the table 1. In the case of Madagascar, the 
monitoring system for multidrug-resistant bacteria is less well 
developed, mainly due to a limited diagnostic infrastructure. 
Cultures are only taken after antibiotic therapy fails and the 
number of hospital infections is undoubtedly underestimated 
[20-23], which justifies our study table 2. The main lines of this 
policy should concern the setting up of a network to monitor 
the antibiotics sensitivity with the collaboration of all the 
laboratories in Madagascar; introduction medical training for 
doctors on the proper use of anti-infective; fight against the 
illicit sale of medicines which promotes self - medication even 
with antibiotics [4]. Escherichia coli multi resistant and other 
enteric bacteria producing extended spectrum β-lactamases 
(ESBLs) have emerged as an important cause of invasive 
infection. Targeting the primary (intestinal) niche with 
decolonization can be a valuable approach to reducing the risk 
of recurrent infections and transmission enteric ESBL 
pathogens [11]. 
CONCLUSION  
Finally, nosocomial infections and antimicrobial resistance are 
becoming increasingly challenging in low-income countries. 
The Malagasy medical scientific community should propose its 
own protocols of probabilistic antibiotic therapies because 
those currently applied are not always in line with the reality 
of antibiotic resistance profiles in our country. The detection 
and quarantine of patients with ESBL at admission to hospital 
is one of the appropriate measures for their eradication. Other 
studies are needed to show the prevalence of ESBL transport 
in Malagasy population and to identify its determinants 
epidemic. 
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